Avicanna Inc. (AVCN.TO)

CAD 0.34

(1.49%)

Net Debt Summary of Avicanna Inc.

  • Avicanna Inc.'s latest annual net debt in 2023 was 1.32 Million CAD , down -34.21% from previous year.
  • Avicanna Inc.'s latest quarterly net debt in 2024 Q2 was 1.07 Million CAD , up 17.58% from previous quarter.
  • Avicanna Inc. reported annual net debt of 2.01 Million CAD in 2022, up 23.57% from previous year.
  • Avicanna Inc. reported annual net debt of 1.63 Million CAD in 2021, up 143.03% from previous year.
  • Avicanna Inc. reported quarterly net debt of 917.12 Thousand CAD for 2024 Q1, down -30.85% from previous quarter.
  • Avicanna Inc. reported quarterly net debt of 1.32 Million CAD for 2023 Q4, down -6.33% from previous quarter.

Annual Net Debt Chart of Avicanna Inc. (2023 - 2016)

Historical Annual Net Debt of Avicanna Inc. (2023 - 2016)

Year Net Debt Net Debt Growth
2023 1.32 Million CAD -34.21%
2022 2.01 Million CAD 23.57%
2021 1.63 Million CAD 143.03%
2020 671.17 Thousand CAD -19.06%
2019 829.2 Thousand CAD 1611.66%
2018 -54.85 Thousand CAD 95.34%
2017 -1.17 Million CAD -6441.88%
2016 18.55 Thousand CAD 0.0%

Peer Net Debt Comparison of Avicanna Inc.

Name Net Debt Net Debt Difference
Aurora Cannabis Inc. -8.64 Million CAD 115.335%
Avant Brands Inc. 17.93 Million CAD 92.603%
Cardiol Therapeutics Inc. -34.77 Million CAD 103.814%
Crescita Therapeutics Inc. -8.13 Million CAD 116.31%
Knight Therapeutics Inc. 10.33 Million CAD 87.162%
MediPharm Labs Corp. -15.68 Million CAD 108.455%
OrganiGram Holdings Inc. -33.7 Million CAD 103.934%
Canopy Growth Corporation 512.87 Million CAD 99.741%
Willow Biosciences Inc. -989 Thousand CAD 234.095%
Auxly Cannabis Group Inc. 142.88 Million CAD 99.072%